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Mast cell growth factor (MGF), a molecule that serves 
as a ligand for the receptor tyrosine kinase c-kit, is 
important in mast cell differentiation, migration, and 
activation. Previous studies of paraffin-embedded 
human skin using antibody to murine MGF and re-
verse transcription-polymerase chain reaction have 
demonstrated MGF protein and mRNA expression in 
keratinocytes and isolated dermal cells. We utilized a 
monoclonal antibody to human MGF to further de-
fine patterns of immunoreactivity in frozen speci-
mens of neonatal and adult skin from normal indi-
viduals and from patients with urticaria pigmentosa. 
In addition to keratinocytes and isolated dermal cells 
in normal and urticaria pigmentosa skin, MGF was 
detected in cells lining superficial and mid-dermal 
vessels. Co-expression of MGF and the vascular anti-
gen CD31, and immunoelectron microscopy, identi-
fied MGF-positive cells as endothelial cells. Patterns 
of endothelial MGF expression were not influenced 
by mast cell degranulation and endothelial E-selectin 
T he mechanism by which mast cell precursors develop into mature mast cells is incompletely understood. It is known that agranu.lar, bone marrow-derived pro-genitors of mast cells must migrate from blood into the dermis where, under the influence of various 
growth factors and cytokines, they mature into chymotryptic 
proteinase (chym ase)- containing connective tissue type mast cells 
(CT MC) [1 ,2]. One of these growth £1ctors is the ligand for the 
tyros ine kinase receptor c·kit [3,4]. T lus facto r, known as c-kit ligand 
[5] , stem cell factor [4], mast cell growth facto r (MG F) [3], and 
Steel factor [6], is encoded by the Steel (SI) locus located on mouse 
chromosome 10 [3, 4] and human chromosome 12 [7]. 
MGF protein has been identified as both a soluble growth factor 
and as a cell-surface molecul e [8]. T he solubl e form a.!one, and in 
syner·gy with several cytokines such as inted eukin-3 (IL-3), IL-4, 
and IL- la, is known to stimulate the development and proliferation 
of melanocytes as well as multiple hematopoietic lineages including 
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induction in vitro. By ultrastructure, unfixed speci-
mens demonstrated MGF expression both within the 
endothelial cytoplasm and in association with lume-
nal, but not ablumenal, surfaces. Specimens fixed 
with Nakane's solution had diminished endothelial 
cytoplasmic MGF reactivity, but lumenal expression 
was maintained, suggesting persistence of a mem-
brane-associated reactivity. MGF mRNA was also 
detected in cultured dermal microvascular endothe-
lial cells using reverse transcription-polymerase 
chain reaction. These data establish human dermal 
endothelial cells as sites of 'MGF production and 
expression in human skin. Mast cell precursors must 
home to skin via vascular channels and differentiate 
in the immediate perivascular space. Thus, endothe-
lial MGF may be an important determinant of adhe-
sion and differentiation of mast cell progenitors ex-
pressing receptors for MGF. Ke)l Ivol,ds: im"1II1Ioelectl'oll 
micl'oscop),/mast cellflll,ticayia pigmelltosa .. ] Invest D el'matol 
104:101-106, 1995 
mast cells [3-5]. Specifically, rat and mouse models have been used 
to show the proliferative effects of recombinant MGF on both 
connective tissue and mucosa.! mast cell lines [9]. Very recently, 
recombinant human MGF was shO\",.n to stimulate the growth and 
differentiation of m ast cells from dispersed human feta.! liver cells 
[2]. 
Longley et nl [10] first demonstrated that keratinocytes can 
produce MGF, and that MGF is normally present in human skin 
associated with keratinocytes in a cytoplasmic pattern. Derma.! 
MGF was associated with cells resembling fibroblasts, perivascular 
dendritic cells , and perhaps endothelial cells. In urticaria pigmen-
tosa, the normal cytoplasmic pattern of human keratinocyte MGF 
expression slufted to an intercellular and dermal pattern su ggesting 
aberrant secretion of a soluble form of MGF. T lus led to the 
hypothesis that alterations in the cutaneous metabolism of MGF 
with subsequent increased levels of soluble MGF may cause both 
the increase in number of dennal ma st cells and the hyperpigmen-
tation that characterize tlus disorder. 
Other studies have focused on t1~e potential role of the trans-
membrane form of MGF in mast cell migration and homing of 
peripheral blood precursors expressin g the MGF receptor [8]. 
While the transmembrane form of MGF is known to share the 
stimulatory effects of the soluble form with regard to cellular 
differentiation [3], it also appears to have properties of an adhesion 
molecule. When COS-7 cells, transfected with cDN A encoding 
either the tran sm embrane or soluble form of MGF, were incubated 
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with murine cultured mast cells, clusters of mast cells adhered only 
to the COS cells expressing the transmembrane MGF [8]. 
In this report, we have used antibodies to human MGF and c-kit 
protein [11] with high ly sensitive detection techniques, and applied 
them to unfixed and fixed tissue to analyze the exprcssion of c-kif 
and its ligand MGF in normal human neonatal foreskin, normal 
ad ult skin, and skin from patients with urticaria pigmentosa. We 
demonstrate expression of MGF by endothelial cell s in all speci-
mens, and confirm the reactivity pattems of MGF previously 
esta blished on normal and urticaria pigmcntosa keratinocytes. MGF 
was found in the cytoplasm and on the lumenal surfaces of dermal 
endothelial cells. Moreover, reverse tran scription and polymerase 
chain reaction (RT-PCR) ampli.fication permitted detection of 
MGF mRNA in severa l derma] microvascular endothelial cell lines. 
These data establish endothelium as a site of synthesis of, and a 
potentially critical expression site of, MGF in human skin . More-
over, they suggest a role for endothelia l MGF in the local adhesion 
and subsequent perivascular differentiation of dermal mast cell 
precursors. 
MATEIUALS AND METHODS 
Tissue Tissue specimens included nconatal foreskin, normal adult skin, 
and skin from patients with cutaneous mastocytosis. Normal human neo-
natal foreskins (n = 4) from e lective surgica l circumcision were obtained 
and immediately immersed in RPM! 1640 media (GIllCO Laboratories, 
Grand Island, NY) containing 10% (v/v) fetal bovine serum, penicillin (100 
IU/ ml), streptomycin (100 }.Lg/ml), and 2 mM L-glutamine. Nonllal adult 
facial skin (n = 4) was obtained from cosmetic surgical procedures. 
Abdominal or forearm biopsies fro m patients with cutaneo us l11<1stocytos is 
(n = 8) were obtained after sub-cutaneous injection of 1 'v., lidoca ine . In 
contrast to previous immunohistochemical studies that employed formalin-
fixed, paraffin-embedded tissue [10], explants were snap frozen in OCT 
embedding compound (Miles, Inc., Elkhart, IN), cooled in liquid nitrogen, 
and stored at - 80°C. 
.,.. . 
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Antibodies Antibod ies used were monoclonal mouse anti-human MGF 
(lgG, isocype, Gcnzyme, Cambridge, MA) ; monoclonal mouse anti-human 
MGF receptor (lgG, isotypc, AMAC, Inc., Westbrook, ME); polyclonal 
rabbit anti-human chymase (courtesy of Dr. Norman Schechter); monoclo-
nal mouse anti-E-selectin (R. & D Systems, Minneapolis , MN); and 
monoclonal mouse anti-CD31 [(plate let-endothelial adhesion molecule-1), 
c1one.5.6 E, AMAC). D etection of chymase permitted specific identification 
of CTMC [1 2] . T he rationa le for usc of anti-E-sclectin was to determine 
whether endothelial MGI' expression dilrered in activated versus resting 
endothelium [13J . Anti-CD31 antibody was utilized as an endothelia l 
marker that has a high degree of spec ificity when used to define cell s lining 
lumenal spaces or in mesenchymal neoplasms [14J. Irrelevant monoclonal 
mouse IgG, antibody, Gl CL (Becton Dickinson, San Jose, CAl, as well as 
a monoclonal mouse IgM antibody (clone DAK-G08, DAKO Corp., 
Carpinteria, CAl were used as nega tive controls. Monoclonal mOllse 
antifibroblast (DAKO) was used as a positive control. 
Foreskin Organ Culture Normal neonatal human foreskin spec imens 
(Caucasian) were obta ined and explants were prepared according to 
teclmiq ues previously described (13). Briefly, explants were subdivided into 
approximately 2 X 2 X 2 mm explants and cultured in scored 34-mm wells 
dermal side down in 1 ml of RPMI media (GIDCO LabOL'atories, as 
described above) alone o r 900 }.LI med ia supplemented with 100 }.LI 
substance P in a 0 .5%, acetic ac id buller at a final concen tration of 5 X 10- 4 
M (S igma Chemical Co., St. Loui s, MO). Experiments using substance P 
were performed to induce endothelial activation by mast cell degranulation 
([13]; assessed by E-selectin induction at 6 h and mast cell chymase 
depletion, respectively). The explants were incubated at 37°C with 5% 
CO2-humidified air. Explants were harvested at 0, 1, 6, and 24 h for each 
condition , w;lshed in PBS, and snap frozen in OCT embedding compound. 
IlnmunohistochClnistry Cryostat sections were ~ ut at 6 }.Lm, air dried 
for 30 min, and fixed in cold acetone for 10 min prior to incubation with 
primary antibodies or irrelevant controls 11 3) . Biotinylated , species-specific 
second layer reagents were applied, fo llowed by ultra-avidin peroxidase 
(Leinco Technologies, Inc., St. Louis, MO). 3,3'-diaminobenzidine (DAB) 
was used as a chromogenic substn.te as previously described [15] . Finall y, 
Figure 1. Immunohistochemistry ofMGF expression in adult dermal endothelium. A : Staining for MGF on flattened cells lining vascu lar (v) spaces 
within nonna l dermis. B: Tissue section adjacent to A; note constitutive expression ofpla tclet endothel.ial ce ll adhesion molecu le-1 (CD31) in same vessel. 
C : Perivascular interstitial ce ll s showing faint apparent MGF membrane sta ining and CD3 1-negativ ity in ;.djac,:nt sections (D) . (A-D, bars, SO }.Lm.) 
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sections were dehydrated and coverslipped. In certain experiments, endo-
thelial cells in tissue sections were co-labeled for MGF and CD31 by 
addition of one primary antibody fo llowed by Auorescein isothiocyanate-
conjugated species-specific secondary an tibody, and next by addition of the 
second primary antibody fo llowed by Texas red- conjugated species-specific 
secondary antibody. Signal was then detected usin g confocal laser scanning 
rn.icroscopy. To prevent cross-reactivi ty, anti-CD31 polyclonal antibody 
produced in rabbi ts was utilized along with murine anti-human MGF. T he 
details of d,is approach have been reported elsewhere [1 6]. In addition to 
the use of irre levant, isotype-matched controls, cross-reactiv;ty was further 
excluded by consistent documentation of absence of CD31 reactivity at sites 
of keratinocyte MGF staining, and by transposition of Auorochromes 0 11 
secondary antibodies. 
IntntU110electro11 Microscopy For ultrastructural localization of MGF, 
samples fro m normal neonatal foreskin were processed as described (1 7). [n 
brief, explan ts were either immediately snap frozen in OCT compound, or 
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fixed in Nakane's fixative for 2 h at 4°C and then washed extensively with 
a 0.1 M sodium phosphate buffer conta.ining 7% sucrose prior to freezing. 
Immunohistochemistry, using the ultra-avidin method as described above, 
was performed on cryostat sections. After development with DAB, sections 
were fixed in 2% glu taraldehyde in 0.1 M cacodylate buffer overnight at 4°C 
and processed for transmission electron microscopy as described previously. 
Ultrathin sections were cut and viewed unstained wid, a Hitachi H-7000 
electron microscope. 
Detection of MGF IDRNA in DerlDal Microvascular Endothelial 
Cells Total RN A was isolated fro m several short-term cell lines estab-
lished fro m human dermal rn.i crovascular endothelial cells, and from a 
transformed endothelial cell line (see (18) for details). RNA was reverse 
tran scribed and the resulting cDNAs were PCR amplified with primers, 
which allowed distinction between cDNAs derived from full-lengm MGF 
mRN A in which ex on 6 has been omitted by alternative splicing (1 0). 
Figure 2. Immunohistochemical comparison of MGF reactivity ill normal and urticaria pigmentosa skin. A,C: Cytoplasmic M~F patte~n. in 
keratlnocytes of normal human neollatal foreskin . B,D: Cell membrane pattern in keratinocytes in lesional urticaria pigmentosa skin. Endoth~ba l cells lirung 
derma l vessels (v ; E) and in terstitial cell s within the perivascular space also stained for MGF. P: Negative con trol vessel (v) reacted WId, Isorype-spec,fic 
irrelevant primary antibody; M , perivascular melanophage con taining particula te cytoplasmic pigment. (A,B,E, .F, /)Ors, 100 /Lm; C,D, bars, 50 /Lm .) 
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Amplification products were electrophoresed in an argarose gel and visu-
alized with ethidium bromide . 
RESULTS 
Immunohistochemistry In frozen sections of normal neonatal 
and adult skin, MGF was detected by routine immwlohistochem-
istry as foci of staining restricted to cells lining structures compat-
ible with dermal vessels (Fig lA,C) and in a granular cytoplasmic 
pattem within keratinocytes (Fig 2A,C). The former cells were 
confirmed to be endothelial cells by co-expression of CD31 in 
adjacent tissue sections (Fig lB,D). Dual labeling using confocal 
scanning laser microscopy permitted simultaneous detection of 
MGF and CD31 co-expression (Fig 3E,F), and immunoelectron 
microscopy (Fig 4) further confirmed MGF localization within 
endothelium. Slight apparent cell-surface reactivity for MGF was 
also observed on CD31-negative interstitial cells surrounding der-
mal vessels (Fig 1). These perivascular cells proved to strongly 
express MGF receptor (Fig 3A-D) , and the majority (> 75%) 
contained metachromatic cytoplasmic granul es (data not shown). 
Dendritic cells within the statum basalis of the epidermis also 
stained for MGF receptor but not MGF; these latter cells were 
presumed to be dilferentiated melanocytes. 
The qualitative pattern and intensity of endothelial MGF expres-
sion did not vary in activated endothelium induced to express 
E-selecti..tl via acute mast cell degranulation in skin explants [13). 
Moreover, in UP skin, where mast cells chronically degranulate, 
the pattem of endothelial reactivity was similar to that observed in 
normal skin (Fig 2) . As reported previously [10], kerati..tlOcytes in 
lesional UP skin showed an intercellular, rather than granular 
cytoplasmic, pattem of MGF expression (Fig 2B,D) . 
Immunoelectron Microscopy To determine the precise sub-
cellular localization of MGF in dermal endothelial ceUs, immuno-
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skin was performed. Frozen tissue (Fig 4A,B) demonstrated dilfuse 
MCF reactivity within the cytoplasm of dermal endothelial cells 
lining superficial microvessels. Increased reactivity was focally 
observed along the lumenal endothelial surfaces (Fig 4B), suggest-
ing the possibility of a membrane-associated component. Examina-
tion of Nakane's-fixed tissue showed cytoplasmic but not lumenal 
surface reactivity for MGF to be ablated. The lumenal surface 
. staining that remained consisted of patchy reactivity for MGF (Fig 
4C), whereas ablumenal regions were negative for MGF and 
strongly reactive for membrane-associated CD31 (data not shown). 
Tlus indicated that selective stallUng of lumenal surfaces for MGF 
was not the result of dilferential accessibility of these two mem-
brane-associated sites to antibody. Cell surfaces other than endo-
thelial lumens failed to show MGF staining in Nakane's-fixed 
normal skin, and endothelial lumenal surfaces were unreactive 
when irrelevant primary antibody was employed, indicating that 
tlus pattern was not an "edge elfect" artifact. Normal keratinocytes 
showed weak, dilfuse cytoplasmic MGF reactivity. 
Detection of Endothelial MGF mRNA Figure 5 shows RT-
PCR detection of MGF mRNA in dermal microvascular endothe-
lial cells. Lanes 2 and 3 represent a control amplification using a 
plasl1ud contallung a full - length MGF cDNA, and a plasmid 
containing a MGF cDNA derived from an altematively-spliced 
RNA, respectively. Amplification of reverse-transcription products 
from an endothelial ceJl line transformed with a fragment of the 
SV40 T antigen (lane 4) revealed the larger MGF transcript. A 
short-term endothelial ceUline (lane 5) contained mRNA encoding 
both forms of MGF. Two other short-term lines also contained 
MGF mRNAs of both sizes. T he identity of the bands was 
confirmed in aU cases by Southem blotting and probing with a 
labeled, intemal oligonucleotide probe. 
c - -
Figure 3. Immunocytochemical and immunofluorescence of specificity of MGF and MGF receptor reactivity patterns. A: An annular array 
of dermal cells expressing MGF receptors approximates the architecture of an arcade of MGF-positive vessels in adjacent section (8) (asterisks , identical 
reference points in the two fields). C,D: Higher magnification of association of MGF receptor-positive cell s (q to MGF-positive dermal vessel (V) (dotted 
!i/le in C demarcates outljne of unstained vessel). E,F: Confocal laser scanni ng microscopy of co-loca lization of MGF (E, Texas red) and CD31 (F, fluorescein 
isothjocyanate) in the Same vessels (A-D, bars, 100 /-L111; E,F, bars, 25 /-L111). • 
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Figure 4. Ilnlnunociectron ltlicroscopy for MGF ill nornlal hlllnall neonatal foreskin skin. A: MGF-positivc vascular spaces dctcctcd 
immunohistochemica ll y ( il/sel) were lincd by endothelial cc lls with diffi.se cytoplasmic rcactivity (Nu. unstained nuclcus) . B: Highcr magnification. Note 
apparent accentuation of reactivity along cndothe lial cell lumenal surf.1ce (II/J~~er tll1'OJ/IS), as well as diffuse cytoplasmic reactivity. Nakanc 's-fixcd tissue (C) 
shows abrogated cytoplasmic rcactivity, but preserved lumena] Surf.1CC sta ining (Im]:er mm l/Is). (SIIItlller tI/HllliS in Band C dcnote ablumena] cndothelial cell 
mcmbrane region.) (A, iltlr, 1 (.Lm ; A iI/SCI, ill/I', 50 (.Lm; B,C, bars, 0.5 (.L1ll . ) 
DISCUSSION 
In this study we demonstrate i) that MGF protein and mRNA is 
constitutively expressed by dermal microvascular endothelium , ii) 
that endothelial M GF exists both within the cell cytoplasm as well 
as on the lumenal surface, and iii) that endothelial M GF expression 
is qualitatively unaltered in association with E-selectin e"'Pression 
or mast cell hyperplasia (urticaria pigmentosa). In add it ion , our data 
confll'ms a surface/intercellular (nlthe r than cytoplasmic) patte rn of 
MGF expression by keratinocytes in lesion al UP skin [10]. 
Soluble MGF can stimula te undifFeren tiated bone-m arrow-de-
rived m ast cell progenitors to develop into mature CTMC [2]. 
Because dermal mast cells are normally situated about microvenulal' 
plexuses that lie just beneath the epiderma l surface, M.GF expres-
sion by endothelial cells may contr ibute to the local differentiation 
and maturation of mas t cells. T his notion is supported further by the 
fi nding of MGF receptor expression on mast cells situated adjacent 
to MGF-positive dermal micl'Ovessels . 
In this study, endothelial lumenal expression of MGF was also 
demonstrated . Although it is difficult to resolve bilaminar plasma 
membranes in tissue prepared for iml11unoelectron microscopy, 
lumenal surface localization suggests that some MGF may be 
endothelial membrane-associated. This potentially transmembrane 
form of MGF was shown to be relatively stable to fixation with 
Nakane's solution, unlike cytoplasl11ic reactivity, which was com-
pletely ablated by that fixative. Kestriction of MGF to lumenal , but 
not ablumenal, endothelial surfaces is similar to the immunoultra-
structural pattern observed for the endothelial-leukocyte adhesion 
molecule E-selectin [19] . R ecent work has provided evidence that 
the transmembrane form of MCF, like E-selectin, can serve as an 
adhesion molecule for certain cells expressing the appropriate 
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Figure 5. RT-PCR-ampl ified MGF mRNA in dermal microvascu-
lar cells. Lalle 1, molecular weigh t markers; lalle 2, contro l amp li fi cation 
using p lasmid contain ing fu li- Iength MGF eDNA; lalle 3, control amp li fi -
cation using plasmid containing MGF cDNA derived from 'Ilternativcly 
sp li ced RNA; lalle 4, amplification of reverse transcription products from 
SV40 T-transfornled endotheljal cell (Ene) line; and lalle 5, ampli fi cation of 
cD NA /Tom short-term endothelial cell line. 
ligand or receptor [8J. Mast cell precursors and peripheral blood 
monocytes are among the hematopoietic progenjtor cells known to 
express the MGF receptor [20]. T hus, MGF expressed on eJldothe-
lial cell membranes may serve to attract CTMC precursors to the 
demlis w here they are then stimulated by secreted MGF to 
diffe rentiate and mature within the perivascu lar space . Mast cells 
induced to develop ill lIityo under the infl uen ce of soluble recom-
binant MGF are less mature and show weaker chymase staining 
than cell s grown in co-culture with fibroblasts that express trans-
membrane MGF [2J. T herefore, it is also possible that the mem-
brane-associated fonn of endothelial M GF may collaborate with 
soluble MGF to ensure the complete d iffe rentiation of CTMC into 
their mature, chymase-conta inmg form. 
Mast ceUs have been shown to express a6 integrin receptors for 
laminjn that may serve to anchor these cell s to vessel basement 
m embran es (21) . R ecent work has also shown th at CTMC differ-
entiated fro m bone-marrow precursors in the presence of soluble 
MGF also are induced to express a4/131 in tegrin (22]. T he two 
ligands fo r this integrill are known to be vascular cell adhesion 
mo lecule and fibronecti n [23 J. T hus, after initia ll y mediating mast 
cell precursor adh erence to the endothelial cell membralle, MGF 
may also serve to promote mast ceU integrin expression that would 
facilitate bindu]g of mast cells to the fibron ectin-rich perivascul ar 
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space. Such integrin-mediated mast cell binding to fibro l~ectin and 
lammin could anchor immature mast ceHs to microvessels as they 
continue to differentiate in response to secre ted M GF and other 
cytokines. 
T lt is "'''rk lI'tlS SIIjJjJi!l1ed by Naliollal IlIslillll es <if H ealilt G rnllis A R 39674, 
CA40358 (GFM), R 2940514, allfllP3 0A R 4 1942 UL) . 
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